ArticleInternational journal of clinical oncology2021

TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway.

Guosheng Tan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.